The burgeoning popularity of Semaglutide for weight management has sparked considerable discussion both within the medical community and among the general audience. Initially approved for treating type 2 diabetes, its remarkable tendency to promote significant body loss has led to its off-label prescription by many. Clinical studies have demonstrat